@RepJamesFrank@DrDiGiorgio@mcuban MLR removes some incentives, but health plans still have to compete for business among employer sponsors, which produces some downward pressure on health plans. But hospitals have so much leverage they can charge exorbitant prices no matter what.
What tools does Mr. Cuban think are available to the health plan to prevent hospital price gouging? They almost certainly have to put the hospital in network, and at that point they have limited ability to steer patients to other sites of service.
Advocacy Alert! Thank you to @WaysandMeansGOP @WaysandMeansDems members for advancing the Main Street Pharmacy Access Act.
This is a key step in improving access to pharmacist-provided care for Medicare patients — in states that already authorize pharmacists to perform these services.
We appreciate AMCP members whose advocacy helped move this forward!
Read press release: https://t.co/u8XzRs4733
#WeAreAMCP #Patientaccess #ECAPS #ManagedCare #Pharmacy #LegislativeDays #AMCPAdvocacy
AMCP’s survey w/ MCPs in @politico Prescription Pulse as #vaccine recommendations evolve. @amcpceo Susan Cantrell warns lawmakers: “Speculating causation without clear clinical evidence flies in the face of how that system is built.”
https://t.co/S0IYyumKy8
Just after midnight on Aug. 7, President Trump’s “reciprocal” tariffs took effect on dozens of international trading partners, marking another escalation of the administration’s “America First” trading policy.
Summary and effects on pharmacy pricing: https://t.co/G6UPt1YSoK
Thanks to @repkevinhern for highlighting Prescription Digital Therapeutics at today’s @WaysandMeansGOP Health Subcommittee hearing on digital health. AMCP honored Rep. Hern and @RepThompson with the Achievement in Pharmacy Policy Award for their work leading the #PDTAccessAct
Former House Speaker Paul Ryan is the #AMCPNexus Keynote Speaker!
From the halls of Congress to the future of health care policy, you won’t want to miss this exclusive session.
📅 Oct. 27–30 | National Harbor, MD
🔗 Register now: https://t.co/rstB4w1GxY
This year, there may be two or more overlapping budget packages likely to contain some of the most significant legislation of 2025. AVP @AdamColborn analyzes what these bills may mean for #managedcare in @FirstReportMC. Learn more here: https://t.co/6CsdkK5k8s
On Jan. 20, President Trump signed numerous Executive Orders focusing on GOP priorities, including withdrawing from the WHO & reversing several Biden-era health policies. Explore each Executive Order impacting managed care: https://t.co/uboFLL8Zfo #HealthPolicy#Inauguration2025
In this #AJMC interview, @AdamColborn of AMCP / @amcporg, discusses #Medicaid efforts to improve access to high-cost therapies.
Watch now! https://t.co/Foux22Gg1Z
.@RepLarryBucshon on ECAPS bill passage and substantial health care legislation on Capitol Hill:
"Honestly, I think that this legislation has caused a pretty substantial discussion on Capitol Hill. And if it doesn't get through Congress this time, I'm hopeful that it will get picked up sometime in the next couple of years."
Watch the full "Boosting the Status Quo: Vaccinating America’s Most Vulnerable" event: https://t.co/c92Wl5fFQh
Sponsored By: @ASCPharm
#TheHillHealth
“I always love to sit down and talk about the incredible work @amcporg members do every single day to make prescriptions more accessible and affordable. Thanks to @HCInnovationGrp for the opportunity!” https://t.co/36lboklxIW
Ready to Switch Things Up? Join us for a chat with Adam Colborn, an expert who breaks down the interchangeability of biosimilars and how they can benefit you. Plus, he shares tips for wider adoption of these medications.
https://t.co/s4i4Szmc2A
Congratulations to Matt Lennertz for being named the @AMCPorg Advocate of the Year in recognition of his commitment to advancing progress in key areas of healthcare.
#wearemedimpact#atruepartner#advocacy
Join us in celebrating our superhero #managedcare#pharmacy professionals, aka "MCPs" through our #WeAreMCPs campaign! Use the virtual photo booth or fun Instagram filter to join the conversation at #AMCP2024! https://t.co/024YdcdKOL
NEW policy brief from MACPAC (@macpacgov) highlights financial challenges of some cell & gene therapies. The MVP Act of 2023 would expand access to lifesaving therapies to our most vulnerable populations: https://t.co/0yIMS5FxHc
Geographic inequality continues to grow each year as pharmacy deserts are on the rise. Access the latest Health Equity Action Brief to gain strategies to address the specific needs of those with geographic disparities. https://t.co/O85sT1WVm3 #healthdisparities
📢We're hiring a Long Term Services and Supports Senior Analyst to lead analytic work on key policy issues affecting #Medicaid and #CHIP. Join a collaborative team committed to personal and team success, inclusivity, and belonging. Apply now!
https://t.co/mEL0b3qnIX
Adam Colborn of @AMCPorg discussed how the recent #ERISA preemption rule influenced employer pharmacy benefits & highlighted a policy that hasn't received much attention in the #managedcarepharmacy space: California's #CalRx Biosimilar Insulin Initiative.
https://t.co/cmlRjwnHB2